Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development
save 25 %
* Required Fields
Pay by invoice
This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the growing demand for innovative therapies as well as the loss of patent exclusivity of the leading pharma products. Across therapy areas, oncology and diabetes emerge as the key contributing segments alongside immunology and cardiovascular diseases. Several small- to mid-sized companies are increasingly focusing on oncology and immunology segments which have high unmet needs and higher acceptability for innovative therapies. Furthermore, across the biologics sub-segments, monoclonal antibodies (mAb) and bioengineered vaccines are amongst the highest contributing segments, with most companies having a strong focus on developing a mAb pipeline. On the other hand, cell and gene therapy are expected to show a strong potential, especially across the rare diseases market, with leading companies like Amgen, Sanofi, Pfizer, etc., investing in molecules in the early stages of clinical development. These molecules, if approved, have the potential of becoming key blockbuster products, propelling the market by more than 20% in the next few years. To achieve expertise across specific therapy areas and biologic sub-segments, bio-pharma companies collaborate with Contract Development and Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs), and digital and medical equipment companies that provide access to innovative proprietary technologies for research and development activities and to optimize the manufacturing process of complex biologics. Alongside industry and academic research collaborations, companies are also focusing on partnering with IT players such as IBM Watson, Intel etc., which provide technologically advanced solutions for conducting clinical trials to support complex drug manufacturing processes, thus creating integrated business models in addition to the above mentioned strategic analysis, a detailed biologic product pipeline, and a SWOT analysis of the key players has been undertaken. Some of the key questions answered by the study include: • What are the current growth opportunities in biologics? What is the impact of the external environment on this market? • Which are the leading companies that are introducing new and innovative products in the market? • How do these companies intend to transform the industry paradigms in the next five years? • What is their strategic focus and potential for growth? • What are the key strategic imperatives in the biologics market? • What are the key strategic collaborations/partnerships and investments made by the companies to stay on the growth trajectory?
European Autoimmune Diagnostics Market, Forecast to 2020
Global Generic Pharmaceuticals Market, Forecast to 2020
Vital Signs The Analyst's Perspective - April 2016 Issue
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022
Pharmaceutical Market Access Strategy for Ethiopia
2016 Indonesia Transformational Health Insights
Global CRO Market, Forecast to 2021
Global Biologics Contract Development & Manufacturing Organization (CDMO) Market—Companies-to-Action
Growth Insights—Real World Evidence Analytics Solutions Market
East African Pharmaceutical Market, Forecast to 2021
fleet management market
smart lighting market
consumer drone market
agricultural drones market
alternative energy market
wound care market
commercial aircraft market forecast
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.